Kenya Murata
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
First Human Infection Case of blaCTX-M-14 -Positive Klebsiella variicola in Japan.
Journal: Japanese journal of infectious diseases
Published: July 30, 2025
Optimizing diagnosis of Bacillus cereus bacteremia using time to positivity: a retrospective observational study to differentiate true bacteremia from contamination.
Journal: BMC infectious diseases
Published: July 01, 2025
Minimum inhibitory concentration of penicillin as a surrogate for in vitro piperacillin susceptibility of ampicillin-susceptible Enterococcus faecalis.
Journal: Diagnostic microbiology and infectious disease
Published: March 11, 2025
A Japanese man with community-onset carbapenem-resistant Stutzerimonas nitrititolerans bacteremia and a sacral pressure ulcer: a case report.
Journal: BMC infectious diseases
Published: November 28, 2024
First case report of "Helicobacter labetoulli" sp nov. bacteraemia in a patient with human immunodeficiency virus in Japan.
Journal: New microbes and new infections
Published: January 04, 2024
Primary syphilis of the oropharynx mimicking a neoplasm.
Journal: International journal of STD & AIDS
Published: March 28, 2023
Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: July 30, 2022
Disseminated Verruconis gallopava infection in a patient with systemic lupus erythematosus in Japan: A case report, literature review, and autopsy case.
Journal: Medical mycology case reports
Published: May 28, 2021
Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data
Journal: Rinsho shinkeigaku = Clinical neurology
Published: November 26, 2019
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
Journal: The Lancet. Neurology
Published: February 06, 2019
Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: July 19, 2017
Last Updated: 09/26/2026